Afferent Pharmaceuticals
Latest round
- Series C
Last raised
- Jul 2015
Total raised
- $78M
Investors
- 9
About Afferent Pharmaceuticals
Founded in 2009 and based in San Mateo, California, Afferent Pharmaceuticals is a bio-pharmaceutical company, focused on developing medicines to treat chronic pain by targeting P2X3 receptors in nerve fibers.
Who invested in Afferent Pharmaceuticals
9 investors across 2 rounds
See all investors in Afferent Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Afferent Pharmaceuticals
Who invested in Afferent Pharmaceuticals?
Afferent Pharmaceuticals has 9 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Afferent Pharmaceuticals raised?
Afferent Pharmaceuticals has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Afferent Pharmaceuticals last raise money?
Afferent Pharmaceuticals's most recent round on record is a Series C, in Jul 2015.
What does Afferent Pharmaceuticals do?
Founded in 2009 and based in San Mateo, California, Afferent Pharmaceuticals is a bio-pharmaceutical company, focused on developing medicines to treat chronic pain by targeting P2X3 receptors in nerve fibers.
Where is Afferent Pharmaceuticals headquartered?
Afferent Pharmaceuticals is headquartered in San Mateo, US.
Which VCs invest in companies like Afferent Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Afferent Pharmaceuticals's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series C
Raising like Afferent Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.